4/24
10:15 am
chrs
Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting [Yahoo! Finance]
Medium
Report
Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting [Yahoo! Finance]
4/24
10:02 am
chrs
Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Medium
Report
Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
4/11
07:25 am
chrs
Investors in Coherus BioSciences (NASDAQ:CHRS) have unfortunately lost 83% over the last five years [Yahoo! Finance]
Low
Report
Investors in Coherus BioSciences (NASDAQ:CHRS) have unfortunately lost 83% over the last five years [Yahoo! Finance]
4/8
08:35 am
chrs
Coherus Presents Preclinical Data for CHS-1000, a Novel Anti-ILT4 Antibody, at the 2024 AACR Annual Meeting [Yahoo! Finance]
Low
Report
Coherus Presents Preclinical Data for CHS-1000, a Novel Anti-ILT4 Antibody, at the 2024 AACR Annual Meeting [Yahoo! Finance]
4/8
08:30 am
chrs
Coherus Presents Preclinical Data for CHS-1000, a Novel Anti-ILT4 Antibody, at the 2024 AACR Annual Meeting
Medium
Report
Coherus Presents Preclinical Data for CHS-1000, a Novel Anti-ILT4 Antibody, at the 2024 AACR Annual Meeting
3/20
08:25 pm
chrs
Coherus Biosciences: Dumping One Drug But Showing Promise With Another [Seeking Alpha]
Low
Report
Coherus Biosciences: Dumping One Drug But Showing Promise With Another [Seeking Alpha]
3/20
08:08 am
chrs
Coherus BioSciences, Inc. (NASDAQ: CHRS) had its price target lowered by analysts at HC Wainwright from $13.00 to $11.00. They now have a "buy" rating on the stock.
Medium
Report
Coherus BioSciences, Inc. (NASDAQ: CHRS) had its price target lowered by analysts at HC Wainwright from $13.00 to $11.00. They now have a "buy" rating on the stock.
3/18
03:09 pm
chrs
Coherus BioSciences, Inc. (NASDAQ: CHRS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $13.00 price target on the stock.
Low
Report
Coherus BioSciences, Inc. (NASDAQ: CHRS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $13.00 price target on the stock.
3/16
03:45 pm
chrs
Coherus BioSciences, Inc. (NASDAQ:CHRS) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Coherus BioSciences, Inc. (NASDAQ:CHRS) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
3/15
05:29 am
chrs
Global Neutropenia Market Competitive Analysis and Forecast Report to 2028, Featuring BeyondSpring Pharmaceuticals, Coherus Biosciences, Myelo Therapeutics and Spectrum Pharmaceuticals [Yahoo! Finance]
Low
Report
Global Neutropenia Market Competitive Analysis and Forecast Report to 2028, Featuring BeyondSpring Pharmaceuticals, Coherus Biosciences, Myelo Therapeutics and Spectrum Pharmaceuticals [Yahoo! Finance]
3/14
06:40 pm
chrs
Why Coherus Biosciences Stock Tumbled on Thursday [Yahoo! Finance]
Low
Report
Why Coherus Biosciences Stock Tumbled on Thursday [Yahoo! Finance]
3/13
04:21 pm
chrs
Coherus BioSciences Reports Fourth Quarter, Full Year 2023 Financial Results and Provides Current Business Update [Yahoo! Finance]
Medium
Report
Coherus BioSciences Reports Fourth Quarter, Full Year 2023 Financial Results and Provides Current Business Update [Yahoo! Finance]
3/13
04:01 pm
chrs
Coherus BioSciences Reports Fourth Quarter, Full Year 2023 Financial Results and Provides Current Business Update
Low
Report
Coherus BioSciences Reports Fourth Quarter, Full Year 2023 Financial Results and Provides Current Business Update
3/6
05:49 am
chrs
In the wake of Coherus BioSciences, Inc.'s (NASDAQ:CHRS) latest US$49m market cap drop, institutional owners may be forced to take severe actions [Yahoo! Finance]
Low
Report
In the wake of Coherus BioSciences, Inc.'s (NASDAQ:CHRS) latest US$49m market cap drop, institutional owners may be forced to take severe actions [Yahoo! Finance]
3/5
04:01 pm
chrs
Coherus to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024
Low
Report
Coherus to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024
3/4
01:08 am
chrs
Coherus Completes Divestiture of Ophthalmology Franchise [Yahoo! Finance]
Medium
Report
Coherus Completes Divestiture of Ophthalmology Franchise [Yahoo! Finance]
3/4
01:00 am
chrs
Coherus Completes Divestiture of Ophthalmology Franchise
Medium
Report
Coherus Completes Divestiture of Ophthalmology Franchise
2/28
07:10 am
chrs
First product based on LTS Sorrel™ wearable drug delivery platform launched in the US [Yahoo! Finance]
Medium
Report
First product based on LTS Sorrel™ wearable drug delivery platform launched in the US [Yahoo! Finance]
2/23
05:33 pm
chrs
Coherus BioSciences Announces New Employment Inducement Grants
Low
Report
Coherus BioSciences Announces New Employment Inducement Grants
2/21
08:44 am
chrs
Coherus Announces U.S. Launch of UDENYCA ONBODY™ a Novel and Proprietary State-of-the-Art Delivery System for pegfilgrastim-cbqv [Yahoo! Finance]
Low
Report
Coherus Announces U.S. Launch of UDENYCA ONBODY™ a Novel and Proprietary State-of-the-Art Delivery System for pegfilgrastim-cbqv [Yahoo! Finance]
2/21
08:30 am
chrs
Coherus Announces U.S. Launch of UDENYCA ONBODY™ a Novel and Proprietary State-of-the-Art Delivery System for pegfilgrastim-cbqv
Medium
Report
Coherus Announces U.S. Launch of UDENYCA ONBODY™ a Novel and Proprietary State-of-the-Art Delivery System for pegfilgrastim-cbqv
2/12
04:50 am
chrs
Injectable Hematology Growth Factors Market Analysis: A Comprehensive Report on the Technological Advancements and Global Opportunities [Yahoo! Finance]
Medium
Report
Injectable Hematology Growth Factors Market Analysis: A Comprehensive Report on the Technological Advancements and Global Opportunities [Yahoo! Finance]
2/9
06:22 am
chrs
Injectable Hematology Growth Factors Report: Shift in As-Supplied Packaging from Single and Multi-use Vials to Prefilled Injection Devices will Accelerate over the Next Five Years [Yahoo! Finance]
High
Report
Injectable Hematology Growth Factors Report: Shift in As-Supplied Packaging from Single and Multi-use Vials to Prefilled Injection Devices will Accelerate over the Next Five Years [Yahoo! Finance]
2/6
05:28 pm
chrs
Why Coherus BioSciences Stock Jumped Today [Yahoo! Finance]
Medium
Report
Why Coherus BioSciences Stock Jumped Today [Yahoo! Finance]
2/5
08:04 am
chrs
Coherus Amends Term Loan Agreement with Pharmakon Advisors, LP [Yahoo! Finance]
Neutral
Report
Coherus Amends Term Loan Agreement with Pharmakon Advisors, LP [Yahoo! Finance]